SOSV launches life sciences incubator in NY with emphasis on therapeutics

The new incubator comes on the heels of SOSV raising $277 mln for its fourth fund. Founder Sean O’Sullivan says the firm is "doubling down on life sciences."

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this